This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • World Health  • Public Health, Other  • Quality of Care  • Patient Safety/ Medical Error  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2008;300(24):2846.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Following a string of serious safety problems with Chinese food and medical products, the US Department of Health and Human Services has established 3 US Food and Drug Administration (FDA) offices in China to facilitate better safety monitoring.

US and Chinese health officials mark the opening of a US Food and Drug Administration office in China that will help monitor the safety of Chinese food and medical products. (Photo credit: Elizabeth Dalziel/AP Images)

According to an announcement by the agency, the 3 FDA offices will be located in the US Embassy in Beijing, the US Consulate General in Guangzhou, and in a Shanghai business complex with other US agencies. The agency also plans to eventually establish offices in India, Europe, Latin America, and the Middle East.

Earlier this year, the FDA confirmed that dozens of patients in the United States and around the world died after receiving . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?